Inhibitory effects of limonin on the proliferation of non-small cell lung cancer cells via targeting S-phase kinase-associated protein 2
Journal Title: Biomedical Transformation - Year 2024, Vol 5, Issue 4
Abstract
Objective Aims to investigate the inhibitory effects of limonin on the proliferation of non-small cell lung cancer (NSCLC) cells and its molecular mechanisms. Methods To investigate the inhibitory effects of limonin on NSCLC cell activity, the MTT assay was employed. Then, flow cytometry was used to detect the cell cycle and apoptosis, while colony formation assay assessed the low-density proliferation ability of NSCLC cells. The matrigel 3D pelletization assay was performed to evaluate stem cell properties. Further, Western blotting was used to analyze the underlying molecular mechanisms of limonin inhibiting NSCLC cell proliferation. Cell thermal shift assay (CETSA) was used to demonstrate the binding capability of limonin with target proteins, and molecular docking was employed to predict the interaction sites between limonin and target proteins. Finally, the study utilized small interfering RNA (siRNA) and S-phase kinase-associated protein 2 (Skp2) overexpressing cell lines to validate the molecular mechanisms of limonin inhibiting NSCLC cell proliferation. Results Limonin inhibited NSCLC cell proliferation in a dose-dependent manner by inducing cell cycle G0/G1 phase arrest while significantly attenuating NSCLC stem cell-like properties. Mechanistically, limonin was bound to the Skp2 protein and induced its downregulation, thus promoting the accumulation of its substrate protein p27. Skp2 knockdown by using Skp2-specific siRNA markedly enhanced the inhibitory effects of limonin on NSCLC cell activity. At the same time, Skp2 overexpression attenuated the capability of limonin to inhibit NSCLC cell activity, further validating the underlying molecular mechanisms of limonin inhibiting NSCLC cell proliferation by targeting Skp2. Conclusion Limonin inhibits NSCLC cell proliferation by targeting Skp2 protein to increase the level of the tumor suppressor protein p27, providing crucial theoretical support for the development of limonin as an antitumor drug.
Authors and Affiliations
Zhu Jiaxian, Zhang Mengting, Li Shengqing, Liu Yongqiang
Keywords
Related Articles
- EP ID EP765867
- DOI 10.12287/j.issn.2096-8965.20240412
- Views 13
- Downloads 0
Progress in research on human enteroviruses
Since the identification of the poliovirus in 1908, over a hundred serotypes of enteroviruses have been discovered, capable of causing a range of diseases including hand, foot, and mouth disease, newborn sepsislike syndr...
Research progress on transgenerational toxicity induced by emerging pollutants and underlying mechanisms in Caenorhabditis elegans
Environmental pollution is closely associated with adverse effects on human health. In recent years, growing attention has been directed toward the environmental distribution and potential toxicity of emerging pollutants...
3-Hydroxybutyrate alleviates septic liver injury by promoting macrophage polarization from M1 to M2
Objective To investigate the therapeutic effects and underlying mechanisms of the metabolite 3- hydroxybutyrate (3HB) in a cecal ligation and puncture (CLP)-induced sepsis model in mice. Methods Male C57BL / 6J mice were...
The myasthenia gravis crisis with titration therapy guided by blood gas monitoring: a case report
Myasthenia gravis (MG) is an autoimmune disease characterized by postsynaptic membrane dysfunction at the neuromuscular junction. It is characterized by muscle fatigue and weakness, and its main antigen target is acetylc...
Application and progress of tissue engineering technology in vaginal reconstruction
Vaginal defects cause immense physical and psychological stress to patients. Traditional vaginal reconstruction methods can partially restore physiological function but are often associated with long treatment periods an...